Market Recap Check: Regenxbio Inc (RGNX)’s Negative Finish at 8.29, Up/Down -0.84

Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.

The price of Regenxbio Inc (NASDAQ: RGNX) closed at $8.29 in the last session, down -0.84% from day before closing price of $8.36. In other words, the price has decreased by -$0.84 from its previous closing price. On the day, 0.64 million shares were traded. RGNX stock price reached its highest trading level at $8.42 during the session, while it also had its lowest trading level at $8.01.

Ratios:

We take a closer look at RGNX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.05 and its Current Ratio is at 3.05. In the meantime, Its Debt-to-Equity ratio is 0.48 whereas as Long-Term Debt/Eq ratio is at 0.37.

On June 07, 2024, Goldman started tracking the stock assigning a Buy rating and target price of $38.Goldman initiated its Buy rating on June 07, 2024, with a $38 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 30 ’24 when VITTAL VASISTA bought 20,041 shares for $7.41 per share.

KARABELAS ARGERIS N sold 10,000 shares of RGNX for $101,052 on Oct 01 ’24. The Director now owns 11,286 shares after completing the transaction at $10.11 per share. On Sep 03 ’24, another insider, KARABELAS ARGERIS N, who serves as the Director of the company, sold 10,000 shares for $11.56 each. As a result, the insider received 115,588 and left with 11,286 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RGNX now has a Market Capitalization of 410728864 and an Enterprise Value of 301079648. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.87 while its Price-to-Book (P/B) ratio in mrq is 1.36. Its current Enterprise Value per Revenue stands at 3.57 whereas that against EBITDA is -1.347.

Stock Price History:

Over the past 52 weeks, RGNX has reached a high of $28.80, while it has fallen to a 52-week low of $7.14. The 50-Day Moving Average of the stock is -8.52%, while the 200-Day Moving Average is calculated to be -33.38%.

Shares Statistics:

According to the various share statistics, RGNX traded on average about 1.12M shares per day over the past 3-months and 1224950 shares per day over the past 10 days. A total of 49.53M shares are outstanding, with a floating share count of 44.85M. Insiders hold about 9.47% of the company’s shares, while institutions hold 90.25% stake in the company. Shares short for RGNX as of 1734048000 were 6229382 with a Short Ratio of 5.57, compared to 1731628800 on 4615030. Therefore, it implies a Short% of Shares Outstanding of 6229382 and a Short% of Float of 16.440001000000002.

Most Popular